Skip to main content

Together we are beating cancer

Donate now

Showing 12 out of 404 results

Can reducing the nicotine content of cigarettes help people quit? Or is it a distraction from tried and trusted strategies? We asked an expert. Can reducing the nicotine content of cigarettes help people quit? Or is it a distraction from tried and trusted strategies? We asked an expert.

by Misha Gajewski | Analysis | 30 September 2015

30 September 2015

A linear accelerator (via Wikimedia Commons)

Giving fewer but higher doses of radiotherapy, is as effective at treating prostate cancer as giving lower doses for a longer period, according to new research Giving fewer but higher doses of radiotherapy, is as effective at treating prostate cancer as giving lower doses for a longer period, according to new research

by Cancer Research UK | News | 28 September 2015

28 September 2015

Over 50 per cent don’t go for new bowel cancer test, we discover a cancer immune shield, The Sun miscalculates and what does it take to call a test a test? Over 50 per cent don’t go for new bowel cancer test, we discover a cancer immune shield, The Sun miscalculates and what does it take to call a test a test?

by Nick Peel | Analysis | 26 September 2015

26 September 2015

Our scientists have discovered that similar to a rugby maul, cancer cells can ward off tumour-killing immune cells through an important cellular signal. Our scientists have discovered that similar to a rugby maul, cancer cells can ward off tumour-killing immune cells through an important cellular signal.

by Alan Worsley | Analysis | 25 September 2015

25 September 2015

Scientists have shown that a class of experimental drug treatments already in clinical trials could also help the body’s immune system to fight cancer. Scientists have shown that a class of experimental drug treatments already in clinical trials could also help the body’s immune system to fight cancer.

by Cancer Research UK | News | 24 September 2015

24 September 2015

Alan
  • Health & Medicine
  • Science & Technology

Our milestones: the birth of abiraterone for prostate cancer

We look back to the 1990s, and to our 'first-in-man' trial of prostate cancer drug abiraterone - a vital step in the drug's development We look back to the 1990s, and to our 'first-in-man' trial of prostate cancer drug abiraterone - a vital step in the drug's development

by Henry Scowcroft | Analysis | 21 September 2015

21 September 2015

This entry is part 24 of 30 in the series Our milestones